“…However, these advanced methods have not yet been widely adopted in clinical practice, in part because they are new, but also because they complicate the perfusion methodology in clinical practice and, when used individually, only address AIF PVE error, obviating the need for the extra effort. For example, AIF problems such as MTT-dependent p svd CBF underestimation (22,29), and the fact that T 2 *-weighted arterial signal concentration estimation is unpredictable (except when the artery is oriented parallel to the main magnetic field, which is not readily testable in vivo) (20), are not corrected by these techniques. Additionally, correcting AIF PVE by scaling the AIF to the signal from a vein without PVE (i.e., a venous output function selected from the superior sagittal sinus) (31) does not seem feasible with DSC-MR because of signal saturation and large susceptibility artifacts that occur in large, extracranial vessels (e.g., internal carotid arteries)-especially at 3 T, which has been our experience.…”